Colorectal Carcinoma with Genetic Abnormalities

Colorectal Carcinoma with Genetic Abnormalities — Trials · CancerIndex

Clinical trials

Registered studies

31 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 27%
Top sponsor: Cancer Research UK
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07384377	JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-Fu, and Irinotecan	not yet recruiting	Phase 3	123	Shanghai JMT-Bio Inc.INDUSTRY	0	Feb 3, 2026	clinicaltrials
NCT01646554	Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases(BOS3)	withdrawn	Phase 2 / Phase 3	0	European Organisation for Research and Treatment of Cancer - EORTCNETWORK